These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Antidepressant medication to prevent depression relapse in primary care: the ANTLER RCT. Duffy L; Clarke CS; Lewis G; Marston L; Freemantle N; Gilbody S; Hunter R; Kendrick T; Kessler D; King M; Lanham P; Mangin D; Moore M; Nazareth I; Wiles N; Bacon F; Bird M; Brabyn S; Burns A; Donkor Y; Hunt A; Pervin J; Lewis G Health Technol Assess; 2021 Nov; 25(69):1-62. PubMed ID: 34842135 [TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of adjunctive bitopertin versus placebo in patients with suboptimally controlled symptoms of schizophrenia treated with antipsychotics: results from three phase 3, randomised, double-blind, parallel-group, placebo-controlled, multicentre studies in the SearchLyte clinical trial programme. Bugarski-Kirola D; Iwata N; Sameljak S; Reid C; Blaettler T; Millar L; Marques TR; Garibaldi G; Kapur S Lancet Psychiatry; 2016 Dec; 3(12):1115-1128. PubMed ID: 27816567 [TBL] [Abstract][Full Text] [Related]
24. Peer support for discharge from inpatient mental health care versus care as usual in England (ENRICH): a parallel, two-group, individually randomised controlled trial. Gillard S; Bremner S; Patel A; Goldsmith L; Marks J; Foster R; Morshead R; White S; Gibson SL; Healey A; Lucock M; Patel S; Repper J; Rinaldi M; Simpson A; Ussher M; Worner J; Priebe S; Lancet Psychiatry; 2022 Feb; 9(2):125-136. PubMed ID: 35065722 [TBL] [Abstract][Full Text] [Related]
25. Cognitive therapy for people with schizophrenia spectrum disorders not taking antipsychotic drugs: a single-blind randomised controlled trial. Morrison AP; Turkington D; Pyle M; Spencer H; Brabban A; Dunn G; Christodoulides T; Dudley R; Chapman N; Callcott P; Grace T; Lumley V; Drage L; Tully S; Irving K; Cummings A; Byrne R; Davies LM; Hutton P Lancet; 2014 Apr; 383(9926):1395-403. PubMed ID: 24508320 [TBL] [Abstract][Full Text] [Related]
26. Predicting psychotic relapse following randomised discontinuation of paliperidone in individuals with schizophrenia or schizoaffective disorder: an individual participant data analysis. Brandt L; Ritter K; Schneider-Thoma J; Siafis S; Montag C; Ayrilmaz H; Bermpohl F; Hasan A; Heinz A; Leucht S; Gutwinski S; Stuke H Lancet Psychiatry; 2023 Mar; 10(3):184-196. PubMed ID: 36804071 [TBL] [Abstract][Full Text] [Related]
27. Therapist-supported online remote behavioural intervention for tics in children and adolescents in England (ORBIT): a multicentre, parallel group, single-blind, randomised controlled trial. Hollis C; Hall CL; Jones R; Marston L; Novere ML; Hunter R; Brown BJ; Sanderson C; Andrén P; Bennett SD; Chamberlain LR; Davies EB; Evans A; Kouzoupi N; McKenzie C; Heyman I; Khan K; Kilgariff J; Glazebrook C; Mataix-Cols D; Murphy T; Serlachius E; Murray E Lancet Psychiatry; 2021 Oct; 8(10):871-882. PubMed ID: 34480868 [TBL] [Abstract][Full Text] [Related]
28. Clinical effectiveness of active Alpha-Stim AID versus sham Alpha-Stim AID in major depression in primary care in England (Alpha-Stim-D): a multicentre, parallel group, double-blind, randomised controlled trial. Morriss R; Patel S; Boutry C; Patel P; Guo B; Briley PM; Butler D; Craven M; Duncan A; Griffiths C; Higton F; McNaughton R; Nixon N; Prasad V; Sayal K; Smart D; Zafar A; Kai J Lancet Psychiatry; 2023 Mar; 10(3):172-183. PubMed ID: 36724796 [TBL] [Abstract][Full Text] [Related]
29. Clinical outcome after antipsychotic treatment discontinuation in functionally recovered first-episode nonaffective psychosis individuals: a 3-year naturalistic follow-up study. Mayoral-van Son J; de la Foz VO; Martinez-Garcia O; Moreno T; Parrilla-Escobar M; Valdizan EM; Crespo-Facorro B J Clin Psychiatry; 2016 Apr; 77(4):492-500. PubMed ID: 26759992 [TBL] [Abstract][Full Text] [Related]
30. Antipsychotic Medication Continuation vs Taper and Discontinuation in Patients With Schizophrenia and Other Nonaffective Psychotic Disorders. Andrade C J Clin Psychiatry; 2024 May; 85(2):. PubMed ID: 38767930 [TBL] [Abstract][Full Text] [Related]
31. Comparison of a theoretically driven cognitive therapy (the Feeling Safe Programme) with befriending for the treatment of persistent persecutory delusions: a parallel, single-blind, randomised controlled trial. Freeman D; Emsley R; Diamond R; Collett N; Bold E; Chadwick E; Isham L; Bird JC; Edwards D; Kingdon D; Fitzpatrick R; Kabir T; Waite F; Lancet Psychiatry; 2021 Aug; 8(8):696-707. PubMed ID: 34246324 [TBL] [Abstract][Full Text] [Related]
32. Risk Factors for Psychotic Relapse After Dose Reduction or Discontinuation of Antipsychotics in Patients With Chronic Schizophrenia. A Meta-Analysis of Randomized Controlled Trials. Bogers JPAM; Hambarian G; Walburgh Schmidt N; Vermeulen JM; de Haan L Schizophr Bull; 2023 Jan; 49(1):11-23. PubMed ID: 36200866 [TBL] [Abstract][Full Text] [Related]
33. A pilot randomised controlled trial of community-led ANtipsychotic Drug REduction for Adults with Learning Disabilities. McNamara R; Randell E; Gillespie D; Wood F; Felce D; Romeo R; Angel L; Espinasse A; Hood K; Davies A; Meek A; Addison K; Jones G; Deslandes P; Allen D; Knapp M; Thapar A; Kerr M Health Technol Assess; 2017 Aug; 21(47):1-92. PubMed ID: 28857740 [TBL] [Abstract][Full Text] [Related]
35. Flupenthixol decanoate (depot) for schizophrenia or other similar psychotic disorders. Mahapatra J; Quraishi SN; David A; Sampson S; Adams CE Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD001470. PubMed ID: 24915451 [TBL] [Abstract][Full Text] [Related]
36. Financial incentives to improve adherence to antipsychotic maintenance medication in non-adherent patients: a cluster randomised controlled trial. Priebe S; Bremner SA; Lauber C; Henderson C; Burns T Health Technol Assess; 2016 Sep; 20(70):1-122. PubMed ID: 27682868 [TBL] [Abstract][Full Text] [Related]
37. Quetiapine extended release versus aripiprazole in children and adolescents with first-episode psychosis: the multicentre, double-blind, randomised tolerability and efficacy of antipsychotics (TEA) trial. Pagsberg AK; Jeppesen P; Klauber DG; Jensen KG; Rudå D; Stentebjerg-Olesen M; Jantzen P; Rasmussen S; Saldeen EA; Lauritsen MG; Bilenberg N; Stenstrøm AD; Nyvang L; Madsen S; Werge TM; Lange T; Gluud C; Skoog M; Winkel P; Jepsen JRM; Fagerlund B; Correll CU; Fink-Jensen A Lancet Psychiatry; 2017 Aug; 4(8):605-618. PubMed ID: 28599949 [TBL] [Abstract][Full Text] [Related]
38. Standard versus reduced dose of antipsychotics for relapse prevention in multi-episode schizophrenia: a systematic review and meta-analysis of randomised controlled trials. Højlund M; Kemp AF; Haddad PM; Neill JC; Correll CU Lancet Psychiatry; 2021 Jun; 8(6):471-486. PubMed ID: 34023019 [TBL] [Abstract][Full Text] [Related]
39. Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia. Declercq T; Petrovic M; Azermai M; Vander Stichele R; De Sutter AI; van Driel ML; Christiaens T Cochrane Database Syst Rev; 2013 Mar; (3):CD007726. PubMed ID: 23543555 [TBL] [Abstract][Full Text] [Related]
40. Cognitive behavioural therapy for adults with dissociative seizures (CODES): a pragmatic, multicentre, randomised controlled trial. Goldstein LH; Robinson EJ; Mellers JDC; Stone J; Carson A; Reuber M; Medford N; McCrone P; Murray J; Richardson MP; Pilecka I; Eastwood C; Moore M; Mosweu I; Perdue I; Landau S; Chalder T; Lancet Psychiatry; 2020 Jun; 7(6):491-505. PubMed ID: 32445688 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]